Cerus Corporation – NASDAQ:CERS
Founder-led company
Cerus stock price today
$1.19
-0.37
-23.72%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 3 hours
Cerus stock price monthly change
-27.44%
month
Cerus stock price quarterly change
-27.44%
quarter
Cerus stock price yearly change
-32.17%
year
Cerus key metrics
Market Cap | 292.50M |
Enterprise value | 554.80M |
P/E | -11.4 |
EV/Sales | 3.42 |
EV/EBITDA | -16.57 |
Price/Sales | 3.10 |
Price/Book | 7.44 |
PEG ratio | -0.45 |
EPS | -0.17 |
Revenue | 163.75M |
EBITDA | -27.44M |
Income | -31.55M |
Revenue Q/Q | 23.86% |
Revenue Y/Y | 5.25% |
Profit margin | -26.4% |
Oper. margin | -21.03% |
Gross margin | 53.75% |
EBIT margin | -21.03% |
EBITDA margin | -16.76% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCerus stock price history
Cerus stock forecast
Cerus financial statements
Average Price Target
$3
Potential upside: 152.10%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 38.85M | -13.27M | -34.17% |
|---|---|---|---|
| Sep 2023 | 39.77M | -7.26M | -18.27% |
| Dec 2023 | 46.76M | -1.32M | -2.84% |
| Mar 2024 | 38.36M | -9.68M | -25.25% |
| Jun 2023 | 198860000 | 147.17M | 74.01% |
|---|---|---|---|
| Sep 2023 | 205844000 | 156.82M | 76.18% |
| Dec 2023 | 197748000 | 144.30M | 72.97% |
| Mar 2024 | 189136000 | 138.97M | 73.48% |
| Jun 2023 | -8.99M | 2.32M | -173K |
|---|---|---|---|
| Sep 2023 | -10.48M | -275K | 7.60M |
| Dec 2023 | -15.01M | 8.21M | 1.01M |
| Mar 2024 | 1.95M | 1.44M | 5.56M |
Cerus alternative data
| Aug 2023 | 665 |
|---|---|
| Sep 2023 | 665 |
| Oct 2023 | 665 |
| Nov 2023 | 665 |
| Dec 2023 | 665 |
| Jan 2024 | 665 |
| Feb 2024 | 665 |
| Mar 2024 | 625 |
| Apr 2024 | 625 |
| May 2024 | 625 |
| Jun 2024 | 625 |
| Jul 2024 | 625 |
Cerus other data
87.23%
+0.31%
of CERS is owned by hedge funds
179
+0
149.41M
+532.33K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 370345 |
| May 2024 | 27000 | 0 |
| Aug 2024 | 0 | 38272 |
| Sep 2024 | 0 | 82657 |
| Dec 2024 | 0 | 36667 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | JENSEN CHRYSTAL officer: Chief Legal Officer | Common Stock | 16,667 | $1.71 | $28,501 | ||
Sale | BJERKHOLT ERIC director | Common Stock | 20,000 | $1.79 | $35,700 | ||
Sale | GREEN KEVIN DENNIS officer: Chief Fi.. | Common Stock | 54,272 | $2.15 | $116,848 | ||
Sale | GREEN KEVIN DENNIS officer: Chief Fi.. | Common Stock | 28,385 | $2.18 | $61,908 | ||
Sale | JENSEN CHRYSTAL officer: Chief Legal Officer | Common Stock | 16,667 | $2.07 | $34,417 | ||
Sale | BENJAMIN RICHARD J officer: Chief Me.. | Common Stock | 21,605 | $2.5 | $54,013 | ||
Purchase | SHAN HUA director | Common Stock | 2,500 | $1.99 | $4,975 | ||
Purchase | NACHTSHEIM JAMI K director | Common Stock | 2,000 | $1.79 | $3,578 | ||
Purchase | SWISHER DANIEL N JR director | Common Stock | 2,500 | $1.88 | $4,690 | ||
Purchase | WITNEY FRANK director | Common Stock | 20,000 | $1.89 | $37,800 |
| Patent |
|---|
Application Filling date: 18 Oct 2021 Issue date: 21 Apr 2022 |
Application Filling date: 16 Dec 2021 Issue date: 7 Apr 2022 |
Application Filling date: 20 Sep 2019 Issue date: 3 Feb 2022 |
Grant Filling date: 2 Mar 2018 Issue date: 1 Feb 2022 |
Application Filling date: 23 Nov 2020 Issue date: 21 Oct 2021 |
Application Filling date: 18 Mar 2021 Issue date: 26 Aug 2021 |
Grant Filling date: 24 Jun 2016 Issue date: 24 Aug 2021 |
Application Filling date: 3 Sep 2020 Issue date: 24 Jun 2021 |
Application Filling date: 26 Jun 2020 Issue date: 31 Dec 2020 |
Application Filling date: 22 Jun 2020 Issue date: 24 Dec 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Cerus stock today?
One share of Cerus stock can currently be purchased for approximately $1.19.
-
When is Cerus's next earnings date?
Unfortunately, Cerus's (CERS) next earnings date is currently unknown.
-
Does Cerus pay dividends?
No, Cerus does not pay dividends.
-
How much money does Cerus make?
Cerus has a market capitalization of 292.50M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 3.51% to 156.37M US dollars.
-
What is Cerus's stock symbol?
Cerus Corporation is traded on the NASDAQ under the ticker symbol "CERS".
-
What is Cerus's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Cerus?
Shares of Cerus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cerus's key executives?
Cerus's management team includes the following people:
- Mr. William M. Greenman Pres, Chief Executive Officer & Director(age: 58, pay: $1,180,000)
- Mr. Vivek K. Jayaraman Chief Operating Officer(age: 50, pay: $739,890)
- Dr. Laurence M. Corash Co-Founder & Chief Scientific Officer(age: 81, pay: $682,320)
- Dr. Richard J. Benjamin Chief Medical Officer(age: 65, pay: $681,620)
- Mr. Kevin D. Green Vice President of Fin. & Chief Financial Officer(age: 53, pay: $654,870)
-
Is Cerus founder-led company?
Yes, Cerus is a company led by its founder Dr. Laurence M. Corash.
-
How many employees does Cerus have?
As Jul 2024, Cerus employs 625 workers.
-
When Cerus went public?
Cerus Corporation is publicly traded company for more then 28 years since IPO on 31 Jan 1997.
-
What is Cerus's official website?
The official website for Cerus is cerus.com.
-
Where are Cerus's headquarters?
Cerus is headquartered at 1220 Concord Avenue, Concord, CA.
-
How can i contact Cerus?
Cerus's mailing address is 1220 Concord Avenue, Concord, CA and company can be reached via phone at +92 52886000.
-
What is Cerus stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Cerus in the last 12 months, the avarage price target is $3. The average price target represents a 152.10% change from the last price of $1.19.
Cerus company profile:
Cerus Corporation
cerus.comExchange:
NASDAQ
Full time employees:
625
Industry:
Medical - Devices
Sector:
Healthcare
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
1220 Concord Avenue
Concord, CA 94520
Concord, CA 94520
CIK: 0001020214
ISIN: US1570851014
CUSIP: 157085101
